These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26658282)

  • 1. Effect of Statin Treatment and Low-Density Lipoprotein-Cholesterol on Short-Term Mortality in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention - Multicenter Registry From Tokyo CCU Network Database.
    Miura M; Yamasaki M; Uemura Y; Yoshikawa M; Miyauchi K; Tanaka H; Miyachi H; Yamashita J; Suzuki M; Yamamoto T; Nagao K; Komuro I; Takayama M
    Circ J; 2016; 80(2):461-8. PubMed ID: 26658282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
    Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
    Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
    Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
    Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
    Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
    J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
    Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
    Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.
    Miura T; Izawa A; Motoki H; Miyashita Y; Kashima Y; Ebisawa S; Tomita T; Koyama J; Ikeda U
    PLoS One; 2015; 10(6):e0127835. PubMed ID: 26083546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
    Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
    J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
    Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox).
    Reddy VS; Bui QT; Jacobs JR; Begelman SM; Miller DP; French WJ;
    Am J Cardiol; 2015 Mar; 115(5):557-62. PubMed ID: 25727079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Treatment by Low-Density Lipoprotein Cholesterol Levels in Patients With Non-ST-Segment Elevation Myocardial Infarction/Unstable Angina Pectoris (from the CRUSADE Registry).
    O'Brien EC; Simon DN; Roe MT; Wang TY; Peterson ED; Alexander KP
    Am J Cardiol; 2015 Jun; 115(12):1655-60. PubMed ID: 25888303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
    Cho KH; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
    Am J Cardiol; 2010 Oct; 106(8):1061-8. PubMed ID: 20920639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.
    Nakahashi T; Tada H; Sakata K; Yakuta Y; Tanaka Y; Nomura A; Gamou T; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Hayashi K; Yamagishi M; Kawashiri MA
    Heart Vessels; 2018 Jul; 33(7):695-705. PubMed ID: 29288404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treat-to-target lipid control is effective but highlighted poor prognosis without indication of statin following percutaneous coronary intervention.
    Tanaka S; Ikari Y; Ijichi T; Nakazawa G
    Cardiovasc Interv Ther; 2017 Oct; 32(4):358-364. PubMed ID: 27539447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
    Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
    Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold level of low-density lipoprotein cholesterol for the short-term benefit of statin therapy in the acute phase of myocardial infarction.
    Lee JH; Park SH; Yang DH; Park HS; Cho Y; Lee WK; Jeong MH; Kim YJ; Jun JE; Chae SC;
    Clin Cardiol; 2012 Apr; 35(4):211-8. PubMed ID: 22102488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
    Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.